How many patents does
Shire Human Genetic Therapies have?
patents
1,500
families
128
granted
254
applications
1,246
US
253
EP
218
WO
146
JP
132
CN
82
KR
26
RoW
643
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Shire Human Genetic Therapies
Top ten assignees appearing on patents
2018
| shire human genetic therapies | 122 |
| translate bio | 89 |
| ethris | 9 |
| rana therapeutics | 1 |
| celldex therapeutics | 1 |
Shire Human Genetic Therapies
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| treatment of sanfilippo syndrome type b | 185 | 2010 |
| purification of iduronate-2-sulfatase | 60 | 2012 |
| cells for producing recombinant iduronate-2-sulfatase | 44 | 2012 |
| diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine… 🛈 | 40 | 2003 |
| compositions and methods for treating gaucher disease | 37 | 2009 |
| medical preparations for the treatment of alpha-galactosidase a deficiency | 35 | 1996 |
| cftr mrna compositions and related methods and uses | 34 | 2013 |
| delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases | 29 | 2009 |
| stabilized composition of glucocerebrosidase | 28 | 2006 |
| therapy for alpha-galactosidase a deficiency | 26 | 1996 |